Duchenne muscular dystrophy (DMD), an X-linked disorder, has an incidence of one in 5000 boys and presents in early childhood with proximal muscle weakness. The disease is caused by mutations in DMD (encoding dystrophin) that abolish the production of dystrophin in muscle. In this study, we aimed to investigate the effect of ozone therapy (OT) on muscle oxygenation in DMD patients. For this purpose, DMD was developed in the primary skeletal muscle cell line. The changes that occurred by administering OT to the cell lines were observed. OT reduced mitochondrial ROS caused by DMD, partially improved the shape changes in myoblasts, but had no effect on dystrophin. OT to DMD patients may have a positive effect on muscle cells.
Primary Language | English |
---|---|
Subjects | Systems Biology |
Journal Section | Research Articles |
Authors | |
Publication Date | March 29, 2024 |
Submission Date | February 18, 2024 |
Acceptance Date | March 27, 2024 |
Published in Issue | Year 2024 Volume: 3 Issue: 1 |
Content of this journal is licensed under a Creative Commons Attribution NonCommercial 4.0 International License